Welch & Forbes’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $88.3M | Sell |
167,666
-515
| -0.3% | -$289K | 1.07% | 25 |
|
|
2026
Q1 | $94.5M | Sell |
168,181
-101
| -0.1% | -$64.8K | 1.22% | 23 |
|
|
2025
Q4 | $114M | Sell |
168,282
-644
| -0.4% | -$439K | 1.38% | 20 |
|
|
2025
Q3 | $108M | Sell |
168,926
-91
| -0.1% | -$55.2K | 1.3% | 21 |
|
|
2025
Q2 | $90.7M | Sell |
169,017
-829
| -0.5% | -$396K | 1.13% | 30 |
|
|
2025
Q1 | $71.3M | Buy |
169,846
+527
| +0.3% | +$229K | 0.93% | 35 |
|
|
2024
Q4 | $70M | Buy |
169,319
+82
| +0% | +$36K | 0.9% | 37 |
|
|
2024
Q3 | $85.5M | Sell |
169,237
-484
| -0.3% | -$235K | 1.09% | 29 |
|
|
2024
Q2 | $81.2M | Sell |
169,721
-505
| -0.3% | -$254K | 1.08% | 28 |
|
|
2024
Q1 | $91.9M | Sell |
170,226
-1,085
| -0.6% | -$593K | 1.26% | 23 |
|
|
2023
Q4 | $95.1M | Sell |
171,311
-1,118
| -0.6% | -$525K | 1.44% | 19 |
|
|
2023
Q3 | $75.4M | Sell |
172,429
-877
| -0.5% | -$437K | 1.25% | 23 |
|
|
2023
Q2 | $87M | Sell |
173,306
-1,108
| -0.6% | -$531K | 1.37% | 20 |
|
|
2023
Q1 | $87.2M | Sell |
174,414
-1,843
| -1% | -$882K | 1.48% | 19 |
|
|
2022
Q4 | $71.9M | Sell |
176,257
-2,274
| -1% | -$883K | 1.29% | 22 |
|
|
2022
Q3 | $58.2M | Sell |
178,531
-471
| -0.3% | -$173K | 1.14% | 27 |
|
|
2022
Q2 | $62.8M | Buy |
179,002
+199
| +0.1% | +$81.1K | 1.15% | 28 |
|
|
2022
Q1 | $97.8M | Buy |
178,803
+4,311
| +2% | +$2.27M | 1.54% | 17 |
|
|
2021
Q4 | $115M | Sell |
174,492
-817
| -0.5% | -$513K | 1.72% | 15 |
|
|
2021
Q3 | $109M | Sell |
175,309
-1,943
| -1% | -$1.31M | 1.81% | 15 |
|
|
2021
Q2 | $112M | Sell |
177,252
-506
| -0.3% | -$279K | 1.89% | 14 |
|
|
2021
Q1 | $87M | Sell |
177,758
-1,928
| -1% | -$966K | 1.61% | 16 |
|
|
2020
Q4 | $89.8M | Sell |
179,686
-1,376
| -0.8% | -$616K | 1.76% | 14 |
|
|
2020
Q3 | $71.2M | Sell |
181,062
-1,606
| -0.9% | -$594K | 1.54% | 17 |
|
|
2020
Q2 | $60.3M | Buy |
182,668
+1,469
| +0.8% | +$425K | 1.41% | 20 |
|
|
2020
Q1 | $43.9M | Buy |
181,199
+492
| +0.3% | +$128K | 1.23% | 23 |
|
|
2019
Q4 | $47.2M | Sell |
180,707
-1,038
| -0.6% | -$274K | 1.05% | 23 |
|
|
2019
Q3 | $49.4M | Buy |
181,745
+1,134
| +0.6% | +$316K | 1.18% | 23 |
|
|
2019
Q2 | $49.7M | Buy |
180,611
+9,419
| +6% | +$2.32M | 1.21% | 23 |
|
|
2019
Q1 | $38.3M | Sell |
171,192
-8,383
| -5% | -$1.73M | 0.96% | 33 |
|
|
2018
Q4 | $33.4M | Sell |
179,575
-1,547
| -0.9% | -$317K | 0.94% | 37 |
|
|
2018
Q3 | $45.2M | Sell |
181,122
-3,458
| -2% | -$839K | 1.08% | 26 |
|
|
2018
Q2 | $40.2M | Sell |
184,580
-1,778
| -1% | -$366K | 1.04% | 31 |
|
|
2018
Q1 | $35.7M | Sell |
186,358
-2,654
| -1% | -$490K | 0.92% | 37 |
|
|
2017
Q4 | $29.6M | Sell |
189,012
-3,984
| -2% | -$627K | 0.79% | 40 |
|
|
2017
Q3 | $30M | Sell |
192,996
-1,403
| -0.7% | -$222K | 0.79% | 44 |
|
|
2017
Q2 | $31.4M | Buy |
194,399
+3,701
| +2% | +$601K | 0.88% | 36 |
|
|
2017
Q1 | $29.5M | Sell |
190,698
-4,546
| -2% | -$627K | 0.84% | 37 |
|
|
2016
Q4 | $22.9M | Buy |
195,244
+80
| +0% | +$9.13K | 0.69% | 53 |
|
|
2016
Q3 | $22M | Sell |
195,164
-3,026
| -2% | -$319K | 0.76% | 44 |
|
|
2016
Q2 | $18.4M | Buy |
198,190
+1,169
| +0.6% | +$100K | 0.56% | 63 |
|
|
2016
Q1 | $15.4M | Sell |
197,021
-2,622
| -1% | -$189K | 0.48% | 71 |
|
|
2015
Q4 | $14.6M | Buy |
199,643
+1,230
| +0.6% | +$87.7K | 0.47% | 71 |
|
|
2015
Q3 | $14.7M | Sell |
198,413
-2,950
| -1% | -$211K | 0.49% | 67 |
|
|
2015
Q2 | $12.9M | Buy |
201,363
+95
| +0% | +$6.58K | 0.4% | 75 |
|
|
2015
Q1 | $15.5M | Sell |
201,268
-7,286
| -3% | -$567K | 0.47% | 71 |
|
|
2014
Q4 | $15.5M | Sell |
208,554
-3,470
| -2% | -$243K | 0.45% | 73 |
|
|
2014
Q3 | $12.5M | Sell |
212,024
-2,102
| -1% | -$133K | 0.38% | 77 |
|
|
2014
Q2 | $14.3M | Sell |
214,126
-10,734
| -5% | -$683K | 0.45% | 70 |
|
|
2014
Q1 | $13.6M | Sell |
224,860
-10,148
| -4% | -$605K | 0.43% | 74 |
|
|
2013
Q4 | $12.5M | Sell |
235,008
-13,142
| -5% | -$692K | 0.4% | 79 |
|
|
2013
Q3 | $12.4M | Sell |
248,150
-6,000
| -2% | -$288K | 0.42% | 77 |
|
|
2013
Q2 | $11.4M | Buy |
+254,150
| New | +$11.1M | 0.41% | 74 |
|
Other funds holding IDXX
Welch & Forbes's IDXX Position: Q2 2026 in Review
Welch & Forbes reduced its Idexx Laboratories (IDXX) stake by 0.31% in Q2 2026, selling an estimated $289K and leaving 167,666 shares worth $88.3M. The position accounts for 1.07% of the portfolio, ranked #25.
Welch & Forbes first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $115M in Q4 2021. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Welch & Forbes held 167,666 shares of Idexx Laboratories worth $88.3M as of Q2 2026.
- Welch & Forbes sold 515 Idexx Laboratories shares in Q2 2026, an estimated $289K.
- Idexx Laboratories made up 1.07% of Welch & Forbes's portfolio in Q2 2026, its #25 holding.
- Welch & Forbes first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
- Welch & Forbes's Idexx Laboratories position peaked at $115M in Q4 2021.
- 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Welch & Forbes's 13F filing for Q2 2026, filed 30 Jul 2026.